Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
DiaMedica Therapeutics Inc. (DMAC)
USD7.57
+0.14 (+1.90%)
US NASDAQ Healthcare Biotechnology
Address
Two Carlson Parkway 55447
Minneapolis, MN, US
Minneapolis, MN, US
CEO
Dietrich John Pauls
Website
diamedica.com
IPO
2012-08-03
CIK 1401040 ISIN CA25253X2077
Description
DiaMedica Therapeutics Inc. operates as a clinical-stage biopharmaceutical entity dedicated to advancing therapeutic solutions for neurological and renal disorders. Its primary drug candidate, DM199, a recombinant human tissue kallikrein-1 protein, is currently undergoing a Phase 2 REDUX trial to assess its efficacy in treating moderate to severe chronic kidney disease linked to Type 1 or Type 2 diabetes. Furthermore, DM199 is being evaluated in Phase 2/3 REMEDY2 trials for acute ischemic stroke patients. In addition to DM199, the company is also developing DM300, which is in its pre-clinical stage for the treatment of various inflammatory conditions. Founded in 2000 and headquartered in Minneapolis, Minnesota, the company was previously known as DiaMedica Inc. before adopting its current name, DiaMedica Therapeutics Inc., in December 2016.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD7.57
+0.14 (+1.90%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
190.3K
Beta
1.00
Float Shares
26.97M
Free Float %
50.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +2.06% | +0.16% | +7.68% | -25.26% | +2.22% | -18.97% | +68.41% | +298.15% | -4.59% | +58.48% | -84.30% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (6 ratings, all time)
Buy
Price Targets & DCF
Current price
7.57
Low
7.00
-7.5%
Consensus
8.33
+10.0%
Median
8.00
+5.7%
High
10.00
+32.1%
DCF (Unlevered)
0.30
-96.0%
DCF (Levered)
0.33
-95.7%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 5 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 3 |
8.33
+10.0%
|
Quality scores
Altman Z-Score
28.91
Safe zone
Piotroski F-Score
2 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%—
-
EPS growth Biotechnology: +29.7%-16.7% Q1'26: -5.6% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%—
-
EBIT margin Biotechnology: +0.0%—
-
ROIC Biotechnology: -16.1%— Q1'26: +1,079.5% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+16.3% Q1'26: +25.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.01× Q1'26: -0.01× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2018 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 3 EPS Ana. |
Dec 2027 3 Rev. Ana. 3 EPS Ana. |
Dec 2028 3 Rev. Ana. 3 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 3.66M (-100.0%)
|
—
est: 3.66M (-100.0%)
|
500.0K
est: 500.0K (+0.0%)
|
—
|
—
|
54.00M
54.00M – 54.00M
|
2.22M
2.22M – 2.22M
-95.9% YoY
|
4.61M
4.61M – 4.61M
+107.6% YoY
|
28.07M
28.07M – 28.07M
+509.2% YoY
|
106.03M
106.03M – 106.03M
+277.7% YoY
|
| EBITDA |
-1.50M
|
-2.15M
|
-5.64M
|
-26.64M
|
-34.35M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EBIT |
-1.50M
|
-2.15M
|
-5.55M
|
-26.68M
|
-34.40M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| Net Income |
-1.44M
est: -73.92M (+98.0%)
|
-2.22M
est: -73.92M (+97.0%)
|
-5.73M
est: -33.54M (+82.9%)
|
-24.44M
est: -23.94M (-2.1%)
|
-32.77M
est: -30.92M (-6.0%)
|
-36.60M
-40.32M – -32.87M
-18.4% YoY
|
-41.36M
-41.36M – -41.36M
-13.0% YoY
|
-40.96M
-63.89M – -18.03M
+1.0% YoY
|
-38.99M
-38.99M – -38.99M
+4.8% YoY
|
-23.33M
-23.33M – -23.33M
+40.2% YoY
|
| SGA |
423.4K
|
718.0K
|
2.74M
|
7.62M
|
9.78M
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
—
— – —
|
| EPS |
-0.40
est: -1.83 (+78.1%)
|
-0.47
est: -1.83 (+74.3%)
|
-0.74
est: -0.83 (+10.8%)
|
-0.60
est: -0.59 (-1.3%)
|
-0.70
est: -0.68 (-2.3%)
|
-0.78
-0.86 – -0.70
-14.6% YoY
|
-0.88
-0.88 – -0.88
-12.3% YoY
|
-1.02
-1.36 – -0.38
-15.9% YoY
|
-0.83
-0.83 – -0.83
+18.6% YoY
|
-0.50
-0.50 – -0.50
+40.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 2/5 | 1/5 | 1/5 | 4/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 3/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-29.12M
OE per share TTM
-0.64
Owner's Yield
-9.92%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
414.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
14
Total invested
2.30M
Insider transactions (90d)
0
Beneficial owners (>5%)
23
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Thomas Von Koch | 2.86M | 10.80% | — | 2.86M | — | 2.86M | IN | Sweden | 2022-07-12 | ↗ |
| 2 | TomEnterprise AB | 2.86M | 10.80% | — | 2.86M | — | 2.86M | FI | Sweden | 2022-07-12 | ↗ |
| 3 | Jan Ståhlberg | 2.55M | 9.60% | — | 2.55M | — | 2.55M | IN | Sweden | 2021-10-08 | ↗ |
| 4 | Trill AB | 2.55M | 9.60% | — | 2.55M | — | 2.55M | FI | Sweden | 2021-10-08 | ↗ |
| 5 | John Fichthorn | 2.21M | 5.20% | — | 2.21M | — | 2.21M | HC, IN | Delaware | 2024-07-08 | ↗ |
| 6 | Dialectic Capital Management, LP | 2.17M | 5.10% | — | 2.17M | — | 2.17M | PN | Delaware | 2024-07-08 | ↗ |
| 7 | Dialectic LS Manager LLC | 2.17M | 5.10% | — | 2.17M | — | 2.17M | OO | Delaware | 2024-07-08 | ↗ |
| 8 | Dialectic Life Sciences SPV LLC | 2.17M | 5.10% | — | 2.17M | — | 2.17M | OO | Delaware | 2024-07-08 | ↗ |
| 9 | Dialectic Partners, LLC | 2.17M | 5.10% | — | 2.17M | — | 2.17M | OO | Delaware | 2024-07-08 | ↗ |
| 10 | 0 | 1.65M | 6.20% | 1.65M | — | 1.65M | — | IN | United States | 2022-05-27 | ↗ |
| 11 | Laurence W. Lytton | 1.38M | 11.00% | 1.38M | — | 1.38M | — | IN | USA | 2021-10-06 | ↗ |
| 12 | Zhenyu Xiao, Ph.D. | 936.8K | 5.00% | 936.8K | — | 936.8K | — | IN | Hong Kong | 2020-12-23 | ↗ |
| 13 | Hermeda Industrial Co., Limited | 929.7K | 4.96% | — | 929.7K | — | — | CO | Hong Kong | 2020-12-23 | ↗ |
| 14 | Jon M. Plexico | 800.0K | 11.00% | 800.0K | — | 800.0K | — | HC, IN | U.S.A. | 2020-02-12 | ↗ |
| 15 | Stonepine Capital Management, LLC | 800.0K | 11.00% | 800.0K | — | 800.0K | — | IA, OO | U.S.A. | 2020-02-12 | ↗ |
| 16 | Stonepine Capital, L.P. | 800.0K | 11.00% | 800.0K | — | 800.0K | — | PN | U.S.A. | 2020-02-12 | ↗ |
| 17 | Timothy P. Lynch | 800.0K | 11.00% | 800.0K | — | 800.0K | — | HC, IN | U.S.A. | 2020-02-12 | ↗ |
| 18 | 27-4413262 | 759.4K | 6.35% | 759.4K | — | 759.4K | — | OO | Maryland | 2019-04-29 | ↗ |
| 19 | Identification Nos. of above persons (. | 759.4K | 6.35% | 759.4K | — | 759.4K | — | IN | States | 2019-04-29 | ↗ |
| 20 | Dr. Albert D. Friesen | 705.9K | 5.90% | 705.9K | — | 705.9K | — | IN | Canada | 2019-01-29 | ↗ |
| 21 | Nancy Chang | 657.9K | 5.50% | 657.9K | — | 657.9K | — | IN | United States | 2019-02-01 | ↗ |
| 22 | CentreStone Ventures Inc. | 598.7K | 5.00% | 598.7K | — | 598.7K | — | CO | Canada | 2019-01-29 | ↗ |
| 23 | CentreStone Ventures Limited Partnership | 598.7K | 5.00% | 598.7K | — | 598.7K | — | PN | Canada | 2019-01-29 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
14
-81 vs prev Q
New positions
1
Closed positions
79
Increased
3
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 95.4K +95.4K (+100.0%) | 759.06M +759.1M (+100.0%) | 0.19% +0.192 pp | 0.75% +0.751 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 2 | COOPERMAN LEON G | 2.02M -1.2M (-38.2%) | 16.08M -1.6M (-8.9%) | 4.07% -3.542 pp | 0.53% -0.017 pp | USD5.11 +55.8% | 21 qtrs — |
| 3 | BLACKROCK, INC. | 1.90M +222.8K (+13.3%) | 15.13M +3.6M (+31.2%) | 3.83% -0.076 pp | 0.00% +0.000 pp | USD5.15 +54.6% | 6 qtrs — |
| 4 | PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 875.0K +— (+0.0%) | 6.97M +953.8K (+15.9%) | 1.76% -0.274 pp | 14.39% +3.672 pp | USD4.61 +72.7% | 11 qtrs — |
| 5 | MILLENNIUM MANAGEMENT LLC | 768.6K -418.7K (-35.3%) | 6.12M -2.0M (-25.0%) | 1.55% -1.215 pp | 0.00% -0.001 pp | USD6.87 +15.9% | 6 qtrs — |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 764.3K +52.4K (+7.4%) | 6.08M +1.2M (+24.4%) | 1.54% -0.117 pp | 0.00% +0.000 pp | USD4.81 +65.5% | 26 qtrs — |
| 7 | VANGUARD GROUP INC | 723.1K +58.5K (+8.8%) | 5.76M +1.2M (+26.1%) | 1.46% -0.090 pp | 0.00% +0.000 pp | USD5.84 +36.3% | 27 qtrs — |
| 8 | STATE STREET CORP | 627.8K +151.2K (+31.7%) | 5.00M +1.7M (+52.6%) | 1.26% +0.156 pp | 0.00% +0.000 pp | USD5.98 +33.1% | 19 qtrs — |
| 9 | MORGAN STANLEY | 547.6K -32.0K (-5.5%) | 4.36M +377.2K (+9.5%) | 1.10% -0.246 pp | 0.00% +0.000 pp | USD5.55 +43.4% | 23 qtrs — |
| 10 | FIRST MANHATTAN CO. LLC. | 405.0K -100.0K (-19.8%) | 3.22M -245.6K (-7.1%) | 0.82% -0.360 pp | 0.01% -0.001 pp | USD2.94 +170.7% | 11 qtrs — |
| 11 | BLEICHROEDER LP | 382.3K +— (+0.0%) | 3.04M +416.7K (+15.9%) | 0.77% -0.120 pp | 0.54% +0.024 pp | USD3.75 +112.3% | 11 qtrs — |
| 12 | NORTHERN TRUST CORP | 325.5K -14.1K (-4.1%) | 2.59M +258.3K (+11.1%) | 0.66% -0.135 pp | 0.00% +0.000 pp | USD4.51 +76.5% | 24 qtrs — |
| 13 | ADVISOR GROUP HOLDINGS, INC. | 247.0K +64.7K (+35.5%) | 1.97M +712.2K (+56.8%) | 0.50% +0.073 pp | 0.00% +0.001 pp | USD5.40 +47.4% | 11 qtrs — |
| 14 | LPL FINANCIAL LLC | 197.2K -6.0K (-3.0%) | 1.57M +173.7K (+12.4%) | 0.40% -0.076 pp | 0.00% +0.000 pp | USD4.16 +91.3% | 7 qtrs — |
| 15 | GOLDMAN SACHS GROUP INC | 129.4K +52.1K (+67.4%) | 1.03M +498.9K (+94.0%) | 0.26% +0.081 pp | 0.00% +0.000 pp | USD7.01 +13.6% | 5 qtrs — |
| 16 | BANK OF NEW YORK MELLON CORP | 121.0K +52.0K (+75.5%) | 963.0K +489.4K (+103.3%) | 0.24% +0.083 pp | 0.00% +0.000 pp | USD5.86 +35.8% | 3 qtrs — |
| 17 | NUVEEN, LLC | 111.0K +36.4K (+48.7%) | 883.8K +370.8K (+72.3%) | 0.22% +0.050 pp | 0.00% +0.000 pp | USD6.31 +26.1% | 3 qtrs — |
| 18 | MEMBERS WEALTH LLC | 101.4K +101.4K (+100.0%) | 864.3K +864.3K (+100.0%) | 0.20% +0.204 pp | 0.54% +0.541 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 19 | WELLINGTON MANAGEMENT GROUP LLP | 103.7K +103.7K (+100.0%) | 825.5K +825.5K (+100.0%) | 0.21% +0.209 pp | 0.00% +0.000 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 20 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 96.9K +4.5K (+4.8%) | 771.2K +136.2K (+21.4%) | 0.20% -0.020 pp | 0.00% +0.000 pp | USD4.54 +75.3% | 11 qtrs — |
| 21 | EAM INVESTORS, LLC | 91.4K +91.4K (+100.0%) | 727.7K +727.7K (+100.0%) | 0.18% +0.184 pp | 0.08% +0.081 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 22 | FRED ALGER MANAGEMENT, LLC | 83.1K +83.1K (+100.0%) | 661.8K +661.8K (+100.0%) | 0.17% +0.168 pp | 0.00% +0.003 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 23 | MAGNOLIA CAPITAL ADVISORS LLC | 77.4K +67.4K (+674.1%) | 616.1K +547.4K (+796.9%) | 0.16% +0.133 pp | 0.13% +0.112 pp | USD7.32 +8.7% | 7 qtrs — |
| 24 | RONALD BLUE TRUST, INC. | 69.1K +— (+0.0%) | 550.2K +75.3K (+15.9%) | 0.14% -0.022 pp | 0.01% +0.001 pp | USD4.64 +71.6% | 6 qtrs — |
| 25 | CREATIVE PLANNING | 58.9K +20.1K (+51.7%) | 468.5K +202.0K (+75.8%) | 0.12% +0.028 pp | 0.00% +0.000 pp | USD7.24 +9.9% | 2 qtrs — |
| 26 | ROYAL BANK OF CANADA | 56.9K +15.0K (+35.7%) | 453.0K +165.0K (+57.3%) | 0.11% +0.017 pp | 0.00% +0.000 pp | USD4.89 +62.8% | 29 qtrs — |
| 27 | SEI INVESTMENTS CO | 55.7K +55.7K (+100.0%) | 443.1K +443.1K (+100.0%) | 0.11% +0.112 pp | 0.00% +0.000 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 28 | BARCLAYS PLC | 52.9K +7.5K (+16.4%) | 421.2K +109.0K (+34.9%) | 0.11% +0.001 pp | 0.00% +0.000 pp | USD4.97 +60.2% | 5 qtrs — |
| 29 | MERIDIAN WEALTH MANAGEMENT, LLC | 50.6K -1.0K (-2.0%) | 403.1K +48.2K (+13.6%) | 0.10% -0.018 pp | 0.01% +0.001 pp | USD6.06 +31.4% | 5 qtrs — |
| 30 | PRIVATE CAPITAL MANAGEMENT, LLC | 50.0K +— (+0.0%) | 398.0K +54.5K (+15.9%) | 0.10% -0.016 pp | 0.04% +0.006 pp | USD6.87 +15.9% | 2 qtrs — |
| 31 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 44.4K +16.0K (+56.5%) | 353.3K +158.4K (+81.3%) | 0.09% +0.023 pp | 0.00% +0.000 pp | USD5.78 +37.7% | 11 qtrs — |
| 32 | WELLS FARGO & COMPANY/MN | 40.6K +18.7K (+85.1%) | 323.4K +172.6K (+114.5%) | 0.08% +0.031 pp | 0.00% +0.000 pp | USD6.30 +26.3% | 4 qtrs — |
| 33 | CATALYST FINANCIAL PARTNERS LLC | 38.5K +— (+0.0%) | 306.1K +41.9K (+15.9%) | 0.08% -0.012 pp | 0.03% +0.002 pp | USD2.44 +226.2% | 13 qtrs — |
| 34 | PENSIONMARK FINANCIAL GROUP, LLC | 37.0K +2.7K (+7.7%) | 294.3K +58.5K (+24.8%) | 0.07% -0.005 pp | 0.00% 0.000 pp | USD5.28 +50.8% | 5 qtrs — |
| 35 | AQR CAPITAL MANAGEMENT LLC | 35.8K +8.3K (+30.3%) | 284.7K +96.1K (+51.0%) | 0.07% +0.008 pp | 0.00% +0.000 pp | USD7.12 +11.8% | 2 qtrs — |
| 36 | MARSHALL WACE, LLP | 32.2K -6.9K (-17.6%) | 256.3K -12.0K (-4.5%) | 0.06% -0.026 pp | 0.00% +0.000 pp | USD3.87 +105.7% | 4 qtrs — |
| 37 | TREXQUANT INVESTMENT LP | 31.0K +31.0K (+100.0%) | 246.4K +246.4K (+100.0%) | 0.06% +0.062 pp | 0.00% +0.002 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 38 | XTX TOPCO LTD | 29.4K +29.4K (+100.0%) | 234.1K +234.1K (+100.0%) | 0.06% +0.059 pp | 0.01% +0.006 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 39 | CITADEL ADVISORS LLC | 27.7K +27.7K (+100.0%) | 220.5K +220.5K (+100.0%) | 0.06% +0.056 pp | 0.00% +0.000 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 40 | RHUMBLINE ADVISERS | 26.8K -596.0 (-2.2%) | 213.0K +25.1K (+13.3%) | 0.05% -0.010 pp | 0.00% +0.000 pp | USD4.28 +86.0% | 3 qtrs — |
| 41 | BANK OF AMERICA CORP /DE/ | 26.3K +14.1K (+114.9%) | 209.5K +125.4K (+149.0%) | 0.05% +0.025 pp | 0.00% +0.000 pp | USD6.49 +22.7% | 9 qtrs — |
| 42 | DEUTSCHE BANK AG\ | 24.4K -8.4K (-25.6%) | 194.0K -31.2K (-13.8%) | 0.05% -0.027 pp | 0.00% +0.000 pp | USD6.87 +15.9% | 2 qtrs — |
| 43 | QUADRATURE CAPITAL LTD | 23.6K +23.6K (+100.0%) | 187.6K +187.6K (+100.0%) | 0.05% +0.048 pp | 0.00% +0.002 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 44 | LOS ANGELES CAPITAL MANAGEMENT LLC | 23.0K +23.0K (+100.0%) | 160.9K +160.9K (+100.0%) | 0.05% +0.046 pp | 0.00% +0.001 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 45 | PRICE T ROWE ASSOCIATES INC /MD/ | 19.7K +— (+0.0%) | 157.0K +21.0K (+15.4%) | 0.04% -0.006 pp | 0.00% +0.000 pp | USD4.85 +64.1% | 3 qtrs — |
| 46 | METLIFE INVESTMENT MANAGEMENT, LLC | 19.1K +9.0K (+89.6%) | 151.9K +82.8K (+119.7%) | 0.04% +0.015 pp | 0.00% +0.000 pp | USD7.39 +7.7% | 2 qtrs — |
| 47 | INVESCO LTD. | 18.6K +4.3K (+29.9%) | 148.3K +49.8K (+50.6%) | 0.04% +0.004 pp | 0.00% +0.000 pp | USD4.91 +62.1% | 3 qtrs — |
| 48 | INTECH INVESTMENT MANAGEMENT LLC | 18.5K +4.5K (+32.5%) | 146.9K +51.2K (+53.5%) | 0.04% +0.005 pp | 0.00% +0.001 pp | USD4.90 +62.4% | 3 qtrs — |
| 49 | STONEBRIDGE CAPITAL ADVISORS LLC | 17.5K +— (+0.0%) | 139.3K +19.1K (+15.9%) | 0.04% -0.006 pp | 0.01% +0.001 pp | USD2.58 +208.5% | 10 qtrs — |
| 50 | BALYASNY ASSET MANAGEMENT L.P. | 17.1K +17.1K (+100.0%) | 136.0K +136.0K (+100.0%) | 0.03% +0.034 pp | 0.00% +0.000 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 51 | CORNERSTONE WEALTH MANAGEMENT, LLC | 16.3K +— (+0.0%) | 129.4K +17.7K (+15.9%) | 0.03% -0.005 pp | 0.01% +0.001 pp | USD3.79 +110.0% | 4 qtrs — |
| 52 | RAYMOND JAMES FINANCIAL INC | 15.8K -20.7K (-56.7%) | 125.8K -125.0K (-49.8%) | 0.03% -0.053 pp | 0.00% +0.000 pp | USD6.23 +27.8% | 5 qtrs — |
| 53 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 15.8K +1.0K (+7.0%) | 125.6K +24.3K (+24.0%) | 0.03% -0.003 pp | 0.00% +0.000 pp | USD4.23 +88.2% | 3 qtrs — |
| 54 | BANK OF MONTREAL /CAN/ | 15.6K +— (+0.0%) | 123.9K +17.0K (+15.9%) | 0.03% -0.005 pp | 0.00% +0.000 pp | USD5.43 +46.6% | 5 qtrs — |
| 55 | GSA CAPITAL PARTNERS LLP | 13.9K +13.9K (+100.0%) | 110.0K +110.0K (+100.0%) | 0.03% +0.028 pp | 0.01% +0.010 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 56 | JPMORGAN CHASE & CO | 13.6K +774.0 (+6.1%) | 107.9K +20.1K (+22.9%) | 0.03% -0.002 pp | 0.00% +0.000 pp | USD4.20 +89.5% | 3 qtrs — |
| 57 | SIMPLEX TRADING, LLC | 12.1K +10.1K (+484.4%) | 96.6K +82.6K (+589.8%) | 0.02% +0.020 pp | 0.00% +0.000 pp | USD7.77 +2.4% | 6 qtrs — |
| 58 | AXQ CAPITAL, LP | 12.1K +12.1K (+100.0%) | 96.1K +96.1K (+100.0%) | 0.02% +0.024 pp | 0.02% +0.022 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 59 | NEW YORK STATE COMMON RETIREMENT FUND | 11.8K +— (+0.0%) | 93.9K +12.9K (+15.9%) | 0.02% -0.004 pp | 0.00% +0.000 pp | USD3.90 +104.1% | 3 qtrs — |
| 60 | JUMP FINANCIAL, LLC | 11.2K +11.2K (+100.0%) | 89.5K +89.5K (+100.0%) | 0.02% +0.023 pp | 0.00% +0.001 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 61 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11.2K +11.2K (+100.0%) | 89.3K +89.3K (+100.0%) | 0.02% +0.023 pp | 0.00% +0.000 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 62 | COLONY GROUP, LLC | 10.5K +10.5K (+100.0%) | 83.7K +83.7K (+100.0%) | 0.02% +0.021 pp | 0.00% +0.000 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 63 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 10.2K +— (+0.0%) | 81.2K +11.1K (+15.9%) | 0.02% -0.003 pp | 0.00% +0.000 pp | USD4.70 +69.4% | 3 qtrs — |
| 64 | TRUVESTMENTS CAPITAL LLC | 9.8K +5.2K (+112.3%) | 78.4K +46.5K (+146.0%) | 0.02% +0.009 pp | 0.01% +0.009 pp | USD6.24 +27.6% | 3 qtrs — |
| 65 | BNP PARIBAS ARBITRAGE, SNC | 7.4K +8.0 (+0.1%) | 59.2K +8.2K (+16.0%) | 0.02% -0.002 pp | 0.00% +0.000 pp | USD3.52 +126.1% | 13 qtrs — |
| 66 | MASSMUTUAL TRUST CO FSB/ADV | 4.8K +— (+0.0%) | 38.4K +5.3K (+15.9%) | 0.01% -0.002 pp | 0.00% +0.000 pp | USD4.01 +98.5% | 18 qtrs — |
| 67 | US BANCORP \DE\ | 4.5K +187.0 (+4.3%) | 36.0K +6.2K (+20.9%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD4.39 +81.3% | 22 qtrs — |
| 68 | FARTHER FINANCE ADVISORS, LLC | 4.2K +4.2K (+100.0%) | 33.7K +33.7K (+100.0%) | 0.01% +0.009 pp | 0.00% +0.000 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 69 | UBS GROUP AG | 3.6K -9.7K (-73.0%) | 28.7K -62.9K (-68.7%) | 0.01% -0.024 pp | 0.00% +0.000 pp | USD5.05 +57.6% | 29 qtrs — |
| 70 | CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 3.6K +3.6K (+100.0%) | 28.7K +28.7K (+100.0%) | 0.01% +0.007 pp | 0.00% +0.002 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 71 | LEGAL & GENERAL GROUP PLC | 3.5K +— (+0.0%) | 28.1K +3.8K (+15.9%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD4.39 +81.3% | 3 qtrs — |
| 72 | AMERITAS INVESTMENT PARTNERS, INC. | 2.7K +— (+0.0%) | 21.5K +2.9K (+15.9%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD3.90 +104.1% | 3 qtrs — |
| 73 | RUSSELL INVESTMENTS GROUP, LTD. | 2.7K -1.3K (-31.9%) | 21.3K -5.7K (-21.1%) | 0.01% -0.004 pp | 0.00% +0.000 pp | USD6.87 +15.9% | 2 qtrs — |
| 74 | STRS OHIO | 2.3K -6.8K (-74.7%) | 18.3K -44.2K (-70.7%) | 0.00% -0.017 pp | 0.00% 0.000 pp | USD4.39 +81.3% | 3 qtrs — |
| 75 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 2.1K +442.0 (+26.8%) | 16.6K +5.3K (+46.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.76 +67.2% | 3 qtrs — |
| 76 | FMR LLC | 1.8K +1.7K (+1,759.8%) | 14.4K +13.7K (+2,056.2%) | 0.00% +0.003 pp | 0.00% +0.000 pp | USD7.90 +0.8% | 2 qtrs — |
| 77 | GROUP ONE TRADING, L.P. | 1.4K +1.0K (+258.9%) | 11.1K +8.4K (+315.8%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD7.40 +7.6% | 3 qtrs — |
| 78 | TOWER RESEARCH CAPITAL LLC (TRC) | 1.4K -1.3K (-49.2%) | 11.0K -7.7K (-41.1%) | 0.00% -0.004 pp | 0.00% 0.000 pp | USD6.87 +15.9% | 22 qtrs — |
| 79 | TD WATERHOUSE CANADA INC. | 1.1K +— (+0.0%) | 8.5K +1.2K (+15.9%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD3.73 +113.4% | 17 qtrs — |
| 80 | CAPITAL ANALYSTS, LLC | 1.1K +1.1K (+100.0%) | 8.0K +8.0K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 81 | AMALGAMATED BANK | 1.1K +164.0 (+18.2%) | 8.0K +2.0K (+33.3%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.52 +76.1% | 3 qtrs — |
| 82 | CITIGROUP INC | 864.00 -579.0 (-40.1%) | 6.9K -3.0K (-30.6%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD4.72 +68.6% | 6 qtrs — |
| 83 | STERLING CAPITAL MANAGEMENT LLC | 206.00 +129.0 (+167.5%) | 1.6K +1.1K (+210.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.62 +20.2% | 3 qtrs — |
| 84 | YANKCOM PARTNERSHIP | 200.00 +200.0 (+100.0%) | 1.6K +1.6K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.001 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 85 | UBS ASSET MANAGEMENT AMERICAS INC | 156.00 +156.0 (+100.0%) | 1.2K +1.2K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.96 +0.0% | 1 qtrs NEW |
| 86 | GLOBAL RETIREMENT PARTNERS, LLC | 130.00 +130.0 (+100.0%) | 1.0K +1.0K (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.95 +0.1% | 1 qtrs NEW |
| 87 | CWM, LLC | 70.00 -16.0 (-18.6%) | 1.0K +— (+0.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD6.86 +16.0% | 2 qtrs — |
| 88 | GAMMA INVESTING LLC | 102.00 +— (+0.0%) | 812.00 +111.0 (+15.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.86 +16.0% | 2 qtrs — |
| 89 | ALLWORTH FINANCIAL LP | 101.00 +16.0 (+18.8%) | 804.00 +220.0 (+37.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.03 +13.2% | 2 qtrs — |
| 90 | CORNERSTONE PLANNING GROUP LLC | 80.00 +74.0 (+1,233.3%) | 675.00 -83.0 (-10.9%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.68 +3.6% | 6 qtrs — |
| 91 | PNC FINANCIAL SERVICES GROUP, INC. | 57.00 -393.0 (-87.3%) | 454.00 -2.6K (-85.3%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD6.86 +16.0% | 2 qtrs — |
| 92 | TORONTO DOMINION BANK | 24.00 +— (+0.0%) | 191.00 +26.0 (+15.8%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD6.83 +16.5% | 2 qtrs — |
| 93 | JANE STREET GROUP, LLC | — -57.5K (-100.0%) | — -395.3K (-100.0%) | 0.00% -0.134 pp | 0.00% 0.000 pp | USD— | 9 qtrs SOLD |
| 94 | CANTOR FITZGERALD, L. P. | — -100.0K (-100.0%) | — -687.0K (-100.0%) | 0.00% -0.233 pp | 0.00% -0.007 pp | USD— | 2 qtrs SOLD |
| 95 | SRS CAPITAL ADVISORS, INC. | — -32.0 (-100.0%) | — -219.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 96 | CORIENT IA LLC | — -132.5K (-100.0%) | — -910.3K (-100.0%) | 0.00% -0.308 pp | 0.00% -0.682 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 27 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Micro-Cap ETF IWC | 0.06% | 943.8K | 0.60% |
| 2 | iShares Russell 2000 Growth ETF IWO | 0.02% | 2.65M | 0.24% |
| 3 | Vanguard Russell 2000 Growth ETF VTWG | 0.01% | 191.5K | 0.06% |
| 4 | Invesco Russell 2000 UCITS ETF RTYS.L | 0.01% | 28.6K | 0.25% |
| 5 | Global X - Russell 2000 ETF RSSL | 0.01% | 131.4K | 0.08% |
| 6 | iShares Russell 2000 BuyWrite ETF IWMW | 0.01% | 5.0K | 0.39% |
| 7 | iShares Russell 2000 ETF IWM | 0.01% | 7.30M | 0.19% |
| 8 | iShares U.S. Small Cap Index ETF (CAD-Hedged) XSU.TO | 0.01% | 47.6K | 0.36% |
| 9 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.01% | 240.2K | 0.30% |
| 10 | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) R2US.L | 0.01% | 338.3K | 0.30% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
3
Sells
0
Shares acquired
4.80M
Shares disposed
—
Cash buys
3.00
Cash sales
—
Net activity
+4,799,999
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-02 | Semba Charles Pauling | Director | A-Award | A | Common Stock | 3,355 | 8.42 | 28.2K | 47,963 | D | ↗ |
| 2026-01-02 | Parsons James T. | Director | A-Award | A | Common Stock | 10,095 | 8.42 | 85.0K | 97,949 | D | ↗ |
| 2026-01-02 | Giuffre Randall Michael | Director | A-Award | A | Common Stock | 6,175 | 8.42 | 52.0K | 398,587 | D | ↗ |
| 2025-11-25 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 73,099 | 8.57 | 626.8K | 8,825,742 | I | ↗ |
| 2025-11-24 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 40,253 | 7.89 | 317.7K | 8,752,643 | I | ↗ |
| 2025-11-21 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 208,872 | 7.41 | 1.55M | 8,712,390 | I | ↗ |
| 2025-11-21 | Parsons James T. | Director | M-Exempt | D | Stock Option (right to buy) | 12,000 | 2.20 | 26.4K | 0 | D | ↗ |
| 2025-11-20 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 128,426 | 7.41 | 951.2K | 8,503,518 | I | ↗ |
| 2025-11-19 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 240,352 | 7.21 | 1.73M | 8,375,092 | I | ↗ |
| 2025-11-18 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 182,882 | 6.75 | 1.23M | 8,134,740 | I | ↗ |
| 2025-11-17 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 187,393 | 6.52 | 1.22M | 7,951,858 | I | ↗ |
| 2025-08-27 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 50,772 | 6.00 | 304.6K | 7,764,465 | I | ↗ |
| 2025-08-26 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 59,648 | 6.00 | 357.9K | 7,713,693 | I | ↗ |
| 2025-08-25 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 338,265 | 6.00 | 2.03M | 7,654,045 | I | ↗ |
| 2025-08-22 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 59,788 | 5.96 | 356.6K | 7,315,780 | I | ↗ |
| 2025-08-21 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 48,172 | 5.96 | 287.0K | 7,255,992 | I | ↗ |
| 2025-08-20 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 71,107 | 5.86 | 416.5K | 7,207,820 | I | ↗ |
| 2025-08-15 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 8,233 | 6.00 | 49.4K | 7,136,713 | I | ↗ |
| 2025-08-14 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 70,414 | 5.99 | 421.9K | 7,128,480 | I | ↗ |
| 2025-08-13 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 293,601 | 5.91 | 1.73M | 7,058,066 | I | ↗ |
| 2025-08-11 | Krop Julie | Officer | A-Award | A | Stock Option (right to buy) | 450,000 | 4.58 | 2.06M | 450,000 | D | ↗ |
| 2025-07-23 | Von Koch Thomas | 10% Owner | P-Purchase | A | Common Shares | 2,857,142 | 3.50 | 10.00M | 8,383,577 | I | ↗ |
| 2025-07-23 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 1,542,857 | 3.50 | 5.40M | 6,764,465 | I | ↗ |
| 2025-07-23 | JACINTO RICHARD II | 10% Owner | P-Purchase | A | Voting Common Shares, no par value per share | 400,000 | 3.50 | 1.40M | 4,958,823 | I | ↗ |
| 2025-06-01 | Wambeke David J. | Officer | A-Award | A | Stock Option (right to buy) | 250,000 | 4.11 | 1.03M | 250,000 | D | ↗ |
| 2025-06-01 | Semba Charles Pauling | Director | A-Award | A | Stock Option (right to buy) | 32,162 | 4.11 | 132.2K | 32,162 | D | ↗ |
| 2025-06-01 | Pauls Dietrich John | Director / Officer | A-Award | A | Stock Option (right to buy) | 600,000 | 4.11 | 2.47M | 600,000 | D | ↗ |
| 2025-06-01 | Parsons James T. | Director | A-Award | A | Stock Option (right to buy) | 40,739 | 4.11 | 167.4K | 40,739 | D | ↗ |
| 2025-06-01 | Lewis Tanya | Director | A-Award | A | Stock Option (right to buy) | 32,162 | 4.11 | 132.2K | 32,162 | D | ↗ |
| 2025-06-01 | Kuntz Richard | Director | A-Award | A | Stock Option (right to buy) | 32,162 | 4.11 | 132.2K | 32,162 | D | ↗ |
| 2025-06-01 | Kellen Scott | Officer | A-Award | A | Stock Option (right to buy) | 225,000 | 4.11 | 924.8K | 225,000 | D | ↗ |
| 2025-06-01 | Giuffre Randall Michael | Director | A-Award | A | Stock Option (right to buy) | 32,162 | 4.11 | 132.2K | 32,162 | D | ↗ |
| 2025-04-07 | Pilnik Richard D. | Director | M-Exempt | A | Voting Common Shares, no par value per share | 24,000 | 2.11 | 50.6K | 312,995 | D | ↗ |
| 2025-02-20 | O'Connor Daniel J. | Director | A-Award | A | Stock Option (right to buy) | 64,242 | 6.61 | 424.6K | 64,242 | D | ↗ |
| 2025-02-13 | Giuffre Randall Michael | Director | M-Exempt | A | Voting Common Shares, no par value per share | 5,000 | 3.65 | 18.3K | 392,412 | D | ↗ |
| 2025-01-02 | Semba Charles Pauling | Director | A-Award | A | Voting Common Shares, no par value per share | 5,290 | 5.34 | 28.2K | 44,608 | D | ↗ |
| 2025-01-02 | Pilnik Richard D. | Director | A-Award | A | Voting Common Shares, no par value per share | 10,393 | 5.34 | 55.5K | 288,995 | D | ↗ |
| 2025-01-02 | Parsons James T. | Director | A-Award | A | Voting Common Shares, no par value per share | 15,917 | 5.34 | 85.0K | 75,854 | D | ↗ |
| 2025-01-02 | Kuntz Richard | Director | A-Award | A | Voting Common Shares, no par value per share | 9,925 | 5.34 | 53.0K | 24,210 | D | ↗ |
| 2025-01-02 | Giuffre Randall Michael | Director | A-Award | A | Voting Common Shares, no par value per share | 10,861 | 5.34 | 58.0K | 375,412 | D | ↗ |
| 2024-06-28 | Von Koch Thomas | 10% Owner | P-Purchase | A | Common Shares | 1,200,000 | 2.50 | 3.00M | 5,526,435 | — | ↗ |
| 2024-06-28 | STAHLBERG JAN | 10% Owner | P-Purchase | A | Common Shares | 1,200,000 | 2.50 | 3.00M | 5,221,608 | — | ↗ |
| 2024-06-01 | Wambeke David J. | Officer | A-Award | A | Stock Option (right to buy) | 130,000 | 2.90 | 377.0K | 130,000 | — | ↗ |
| 2024-06-01 | Semba Charles Pauling | Director | A-Award | A | Stock Option (right to buy) | 28,472 | 2.90 | 82.6K | 28,472 | — | ↗ |
| 2024-06-01 | Pilnik Richard D. | Director | A-Award | A | Stock Option (right to buy) | 36,065 | 2.90 | 104.6K | 36,065 | — | ↗ |
| 2024-06-01 | Pauls Dietrich John | Director / Officer | A-Award | A | Stock Option (right to buy) | 300,000 | 2.90 | 870.0K | 300,000 | — | ↗ |
| 2024-06-01 | Parsons James T. | Director | A-Award | A | Stock Option (right to buy) | 28,472 | 2.90 | 82.6K | 28,472 | — | ↗ |
| 2024-06-01 | Lewis Tanya | Director | A-Award | A | Stock Option (right to buy) | 28,472 | 2.90 | 82.6K | 28,472 | — | ↗ |
| 2024-06-01 | Kuntz Richard | Director | A-Award | A | Stock Option (right to buy) | 28,472 | 2.90 | 82.6K | 28,472 | — | ↗ |
| 2024-06-01 | Kellen Scott | Officer | A-Award | A | Stock Option (right to buy) | 130,000 | 2.90 | 377.0K | 130,000 | — | ↗ |
| 2024-06-01 | Giuffre Randall Michael | Director | A-Award | A | Stock Option (right to buy) | 28,472 | 2.90 | 82.6K | 28,472 | — | ↗ |
| 2024-06-01 | Cundari Dominic R | Officer | A-Award | A | Stock Option (right to buy) | 15,000 | 2.90 | 43.5K | 15,000 | — | ↗ |
| 2024-01-22 | Lorianne Masuoka K. | Officer | A-Award | A | Stock option (right to buy) | 285,000 | 2.79 | 795.2K | 285,000 | — | ↗ |
| 2024-01-02 | Semba Charles Pauling | Director | A-Award | A | Voting Common Shares, no par value per share | 9,375 | 2.80 | 26.3K | 39,318 | — | ↗ |
| 2024-01-02 | Pilnik Richard D. | Director | A-Award | A | Voting Common Shares, no par value per share | 30,357 | 2.80 | 85.0K | 278,602 | — | ↗ |
| 2024-01-02 | Parsons James T. | Director | A-Award | A | Voting Common Shares, no par value per share | 21,428 | 2.80 | 60.0K | 59,937 | — | ↗ |
| 2024-01-02 | Kuntz Richard | Director | A-Award | A | Voting Common Shares, no par value per share | 14,285 | 2.80 | 40.0K | 14,285 | — | ↗ |
| 2024-01-02 | Giuffre Randall Michael | Director | A-Award | A | Voting Common Shares, no par value per share | 19,196 | 2.80 | 53.7K | 364,551 | — | ↗ |
| 2023-11-16 | Wambeke David J. | Officer | P-Purchase | A | Voting Common Shares, no par value per share | 20,000 | 2.46 | 49.2K | 527,114 | — | ↗ |
| 2023-06-23 | Wambeke David J. | Officer | P-Purchase | A | Voting Common Shares, no par value per share | 38,364 | 3.91 | 150.0K | 507,114 | — | ↗ |
| 2023-06-23 | Von Koch Thomas | 10% Owner | P-Purchase | A | Common Shares | 1,470,588 | 3.40 | 5.00M | 4,326,435 | — | ↗ |
| 2023-06-23 | Semba Charles Pauling | Director | P-Purchase | A | Voting Common Shares, no par value per share | 12,787 | 3.91 | 50.0K | 29,943 | — | ↗ |
| 2023-06-23 | STAHLBERG JAN | 10% Owner | — | I | Common Shares | 0 | 0.00 | — | 4,021,608 | — | ↗ |
| 2023-06-23 | Pilnik Richard D. | Director | P-Purchase | A | Voting Common Shares, no par value per share | 38,363 | 3.91 | 150.0K | 248,245 | — | ↗ |
| 2023-06-23 | Pauls Dietrich John | Director / Officer | P-Purchase | A | Voting Common Shares, no par value per share | 12,787 | 3.91 | 50.0K | 68,591 | — | ↗ |
| 2023-06-23 | Kellen Scott | Officer | P-Purchase | A | Voting Common Shares, no par value per share | 10,000 | 3.91 | 39.1K | 32,290 | — | ↗ |
| 2023-06-23 | JACINTO RICHARD II | 10% Owner | — | I | Voting Common Shares, no par value per share | 0 | 0.00 | — | 4,558,823 | — | ↗ |
| 2023-06-23 | Giuffre Randall Michael | Director | G-Gift | D | Voting Common Shares, no par value per share | 15,000 | 0.00 | — | 345,355 | — | ↗ |
| 2023-06-01 | Semba Charles Pauling | Director | A-Award | A | Stock Option (right to buy) | 16,968 | 2.73 | 46.3K | 16,968 | — | ↗ |
| 2023-06-01 | Pilnik Richard D. | Director | A-Award | A | Stock Option (right to buy) | 22,355 | 2.73 | 61.0K | 22,355 | — | ↗ |
| 2023-06-01 | Pauls Dietrich John | Director / Officer | A-Award | A | Stock option (right to buy) | 181,000 | 2.73 | 494.1K | 181,000 | — | ↗ |
| 2023-06-01 | Parsons James T. | Director | A-Award | A | Stock Option (right to buy) | 16,968 | 2.73 | 46.3K | 16,968 | — | ↗ |
| 2023-06-01 | Lewis Tanya | Director | A-Award | A | Stock Option (right to buy) | 7,493 | 2.73 | 20.5K | 7,493 | — | ↗ |
| 2023-06-01 | Kellen Scott | Officer | A-Award | A | Stock Option (right to buy) | 67,000 | 2.73 | 182.9K | 67,000 | — | ↗ |
| 2023-06-01 | Gruis Kirsten L | Officer | A-Award | A | Stock Option (right to buy) | 67,000 | 2.73 | 182.9K | 67,000 | — | ↗ |
| 2023-06-01 | Giuffre Randall Michael | Director | A-Award | A | Stock Option (right to buy) | 16,968 | 2.73 | 46.3K | 16,968 | — | ↗ |
| 2023-06-01 | Daves Julie VanOrsdel | Officer | A-Award | A | Stock Option (right to buy) | 54,000 | 2.73 | 147.4K | 54,000 | — | ↗ |
| 2023-06-01 | Cundari Dominic R | Officer | A-Award | A | Stock Option (right to buy) | 27,000 | 2.73 | 73.7K | 27,000 | — | ↗ |
| 2023-05-30 | Kuntz Richard | Director | A-Award | A | Stock option (right to buy) | 32,320 | 2.81 | 90.8K | 32,320 | — | ↗ |
| 2023-04-10 | Wambeke David J. | Officer | A-Award | A | Stock Option (right to buy) | 140,000 | 1.57 | 219.8K | 140,000 | — | ↗ |
| 2023-03-01 | Lewis Tanya | Director | A-Award | A | Stock option (right to buy) | 26,443 | 1.77 | 46.8K | 26,443 | — | ↗ |
| 2023-01-03 | Semba Charles Pauling | Director | A-Award | A | Voting Common Shares, no par value per share | 17,156 | 1.53 | 26.2K | 17,156 | — | ↗ |
| 2023-01-03 | Pilnik Richard D. | Director | A-Award | A | Voting Common Shares, no par value per share | 55,555 | 1.53 | 85.0K | 209,882 | — | ↗ |
| 2023-01-03 | Giuffre Randall Michael | Director | A-Award | A | Voting Common Shares, no par value per share | 35,130 | 1.53 | 53.7K | 295,355 | — | ↗ |
| 2023-01-03 | Burroughs Amy L. | Director | A-Award | A | Voting Common Shares, no par value per share | 17,156 | 1.53 | 26.2K | 73,288 | — | ↗ |
| 2022-12-09 | Giuffre Randall Michael | Director | P-Purchase | A | Voting Common Shares, no par value per share | 37,079 | 1.43 | 53.0K | 260,225 | — | ↗ |
| 2022-12-08 | Giuffre Randall Michael | Director | P-Purchase | A | Voting Common Shares, no par value per share | 20,000 | 1.40 | 28.0K | 223,146 | — | ↗ |
| 2022-12-07 | Giuffre Randall Michael | Director | P-Purchase | A | Voting Common Shares, no par value per share | 22,574 | 1.40 | 31.6K | 203,146 | — | ↗ |
| 2022-12-06 | Giuffre Randall Michael | Director | P-Purchase | A | Voting Common Shares, no par value per share | 2,300 | 1.35 | 3.1K | 180,572 | — | ↗ |
| 2022-12-05 | Pilnik Richard D. | Director | P-Purchase | A | Voting Common Shares, no par value per share | 35,000 | 1.39 | 48.5K | 154,327 | — | ↗ |
| 2022-12-02 | Von Koch Thomas | Director | S-Sale | D | Common Shares | 2,855,847 | 1.24 | 3.53M | 0 | — | ↗ |
| 2022-12-01 | Giuffre Randall Michael | Director | P-Purchase | A | Voting Common Shares, no par value per share | 819 | 1.19 | 974.61 | 178,272 | — | ↗ |
| 2022-11-30 | Giuffre Randall Michael | Director | P-Purchase | A | Voting Common Shares, no par value per share | 2,970 | 1.19 | 3.5K | 131,320 | — | ↗ |
| 2022-11-29 | Giuffre Randall Michael | Director | P-Purchase | A | Voting Common Shares, no par value per share | 18,125 | 1.19 | 21.6K | 128,350 | — | ↗ |
| 2022-11-16 | Pauls Dietrich John | Officer | P-Purchase | A | Voting Common Shares, no par value per share | 20,000 | 1.21 | 24.2K | 55,804 | — | ↗ |
| 2022-07-08 | Von Koch Thomas | 10% Owner | — | I | Common Shares | 0 | 0.00 | — | 2,647,873 | — | ↗ |
| 2022-07-08 | TomEnterprise AB | Director | P-Purchase | A | Common Shares | 207,974 | 1.33 | 275.9K | 2,855,827 | — | ↗ |
| 2022-06-01 | Semba Charles Pauling | Director | A-Award | A | Stock Option (right to buy) | 13,222 | 0.00 | — | 13,222 | — | ↗ |
| 2022-06-01 | Pilnik Richard D. | Director | A-Award | A | Stock Option (right to buy) | 18,510 | 0.00 | — | 18,510 | — | ↗ |
| 2022-06-01 | Pauls Dietrich John | Director / Officer | A-Award | A | Stock Option (right to buy) | 177,000 | 2.45 | 433.7K | 177,000 | — | ↗ |
| 2022-06-01 | Parsons James T. | Director | A-Award | A | Stock Option (right to buy) | 13,222 | 2.45 | 32.4K | 13,222 | — | ↗ |
| 2022-06-01 | Kellen Scott | Officer | A-Award | A | Stock Option (right to buy) | 60,000 | 0.00 | — | 60,000 | — | ↗ |
| 2022-06-01 | Giuffre Randall Michael | Director | A-Award | A | Stock Option (right to buy) | 13,222 | 2.45 | 32.4K | 13,222 | — | ↗ |
| 2022-06-01 | Burroughs Amy L. | Director | A-Award | A | Stock Option (right to buy) | 13,222 | 0.00 | — | 13,222 | — | ↗ |
| 2022-02-01 | Cundari Dominic R | Officer | A-Award | A | Stock Option (right to buy) | 125,000 | 2.90 | 362.5K | 125,000 | — | ↗ |
| 2022-01-03 | Pilnik Richard D. | Director | A-Award | A | Voting Common Shares, no par value per share | 23,762 | 3.58 | 85.1K | 119,327 | — | ↗ |
| 2022-01-03 | Parsons James T. | Director | A-Award | A | Voting Common Shares, no par value per share | 16,773 | 3.58 | 60.0K | 38,509 | — | ↗ |
| 2022-01-03 | Gruis Kirsten L | Officer | A-Award | A | Stock Option (right to buy) | 160,000 | 3.88 | 620.8K | 160,000 | — | ↗ |
| 2022-01-03 | Giuffre Randall Michael | Director | A-Award | A | Voting Common Shares, no par value per share | 15,026 | 3.58 | 53.8K | 110,225 | — | ↗ |
| 2022-01-03 | Burroughs Amy L. | Director | A-Award | A | Voting Common Shares, no par value per share | 11,182 | 3.58 | 40.0K | 56,132 | — | ↗ |
| 2021-09-15 | ALCORN HARRY W JR | Officer | P-Purchase | A | Voting Common Shares, no par value per share | 15,000 | 3.80 | 57.0K | 43,582 | — | ↗ |
| 2021-08-16 | Pilnik Richard D. | Director | P-Purchase | A | Voting Common Shares, no par value per share | 12,500 | 3.28 | 41.0K | 95,565 | — | ↗ |
| 2021-08-16 | Pauls Dietrich John | Director / Officer | P-Purchase | A | Voting Common Shares, no par value per share | 5,000 | 3.14 | 15.7K | 35,804 | — | ↗ |
| 2021-08-16 | Kellen Scott | Officer | P-Purchase | A | Voting Common Shares, no par value per share | 10,000 | 3.15 | 31.5K | 22,290 | — | ↗ |
| 2021-08-16 | Burroughs Amy L. | Director | P-Purchase | A | Voting Common Shares, no par value per share | 44,950 | 3.15 | 141.6K | 44,950 | — | ↗ |
| 2021-08-16 | ALCORN HARRY W JR | Officer | P-Purchase | A | Voting Common Shares, no par value per share | 322 | 3.06 | 984.93 | 28,582 | — | ↗ |
| 2021-07-28 | Pauls Dietrich John | Director / Officer | A-Award | A | Stock Option (right to buy) | 175,000 | 5.00 | 875.0K | 175,000 | — | ↗ |
| 2021-07-28 | Kellen Scott | Officer | A-Award | A | Stock Option (right to buy) | 60,000 | 5.00 | 300.0K | 60,000 | — | ↗ |
| 2021-07-28 | Gilman Sydney A. | Officer | A-Award | A | Stock Option (right to buy) | 25,000 | 5.00 | 125.0K | 25,000 | — | ↗ |
| 2021-07-28 | ALCORN HARRY W JR | Officer | A-Award | A | Stock Option (right to buy) | 60,000 | 5.00 | 300.0K | 60,000 | — | ↗ |
| 2021-07-15 | Semba Charles Pauling | Director | A-Award | A | Stock Option (right to buy) | 18,786 | 3.64 | 68.4K | 18,786 | — | ↗ |
| 2021-07-15 | Pilnik Richard D. | Director | A-Award | A | Stock Option (right to buy) | 13,150 | 3.64 | 47.9K | 13,150 | — | ↗ |
| 2021-07-15 | Parsons James T. | Director | A-Award | A | Stock Option (right to buy) | 9,393 | 3.64 | 34.2K | 9,393 | — | ↗ |
| 2021-07-15 | Giuffre Randall Michael | Director | A-Award | A | Stock Option (right to buy) | 9,393 | 3.64 | 34.2K | 9,393 | — | ↗ |
| 2021-07-15 | Burroughs Amy L. | Director | A-Award | A | Stock Option (right to buy) | 18,786 | 3.64 | 68.4K | 18,786 | — | ↗ |
| 2021-01-01 | Pilnik Richard D. | Director | A-Award | A | Voting Common Shares, no par value per share | 9,719 | 8.23 | 80.0K | 80,565 | — | ↗ |
| 2021-01-01 | Parsons James T. | Director | A-Award | A | Voting Common Shares, no par value per share | 7,745 | 8.23 | 63.7K | 21,947 | — | ↗ |
| 2021-01-01 | Giuffre Randall Michael | Director | A-Award | A | Voting Common Shares, no par value per share | 7,441 | 8.23 | 61.2K | 116,029 | — | ↗ |
| 2020-12-04 | Pilnik Richard D. | Director | P-Purchase | A | Voting Common Shares, no par value per share | 5,000 | 5.24 | 26.2K | 70,846 | — | ↗ |
| 2020-11-20 | Giuffre Randall Michael | Director | P-Purchase | A | Voting Common Shares, no par value per share | 15,000 | 4.26 | 63.9K | 108,588 | — | ↗ |
| 2020-11-09 | Kellen Scott | Officer | P-Purchase | A | Voting Common Shares, no par value per share | 2,000 | 4.19 | 8.4K | 12,290 | — | ↗ |
| 2020-06-01 | Pilnik Richard D. | Director | A-Award | A | Stock Option (right to buy) | 19,220 | 4.64 | 89.2K | 19,220 | — | ↗ |
| 2020-06-01 | Pauls Dietrich John | Director / Officer | A-Award | A | Stock Option (right to buy) | 56,000 | 4.64 | 259.8K | 56,000 | — | ↗ |
| 2020-06-01 | Parsons James T. | Director | A-Award | A | Stock Option (right to buy) | 13,306 | 4.64 | 61.7K | 13,306 | — | ↗ |
| 2020-06-01 | Kellen Scott | Officer | A-Award | A | Stock Option (right to buy) | 35,000 | 4.64 | 162.4K | 35,000 | — | ↗ |
| 2020-06-01 | Giuffre Randall Michael | Director | A-Award | A | Stock Option (right to buy) | 13,306 | 4.64 | 61.7K | 13,306 | — | ↗ |
| 2020-06-01 | Gilman Sydney A. | Officer | A-Award | A | Stock Option (right to buy) | 17,500 | 4.64 | 81.2K | 17,500 | — | ↗ |
| 2020-06-01 | ALCORN HARRY W JR | Officer | A-Award | A | Stock Option (right to buy) | 35,000 | 4.64 | 162.4K | 35,000 | — | ↗ |
| 2019-11-01 | Gilman Sydney A. | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-08-19 | Kellen Scott | Officer | P-Purchase | A | Voting Common Shares, no par value per share | 3,000 | 2.43 | 7.3K | 10,290 | — | ↗ |
| 2019-08-16 | Pilnik Richard D. | Director | P-Purchase | A | Voting Common Shares, no par value per share | 7,840 | 2.56 | 20.0K | 50,678 | — | ↗ |
| 2019-08-16 | Pauls Dietrich John | Director / Officer | P-Purchase | A | Voting Common Shares, no par value per share | 1,000 | 2.68 | 2.7K | 30,804 | — | ↗ |
| 2019-08-16 | ALCORN HARRY W JR | Officer | P-Purchase | A | Voting Common Shares, no par value per share | 7,260 | 2.67 | 19.4K | 8,260 | — | ↗ |
| 2019-06-24 | Xiao Zhenyu | Director | A-Award | A | Stock Option (right to buy) | 12,950 | 4.60 | 59.6K | 12,950 | — | ↗ |
| 2019-06-24 | Verdoorn Todd A. | Officer | A-Award | A | Stock Option (right to buy) | 71,025 | 4.60 | 326.7K | 71,025 | — | ↗ |
| 2019-06-24 | Pilnik Richard D. | Director | A-Award | A | Stock Option (right to buy) | 18,700 | 4.60 | 86.0K | 18,700 | — | ↗ |
| 2019-06-24 | Pauls Dietrich John | Director / Officer | A-Award | A | Stock Option (right to buy) | 264,000 | 4.60 | 1.21M | 264,000 | — | ↗ |
| 2019-06-24 | Parsons James T. | Director | A-Award | A | Stock Option (right to buy) | 12,950 | 4.60 | 59.6K | 12,950 | — | ↗ |
| 2019-06-24 | Kellen Scott | Officer | A-Award | A | Stock Option (right to buy) | 99,750 | 4.60 | 458.9K | 99,750 | — | ↗ |
| 2019-06-24 | Giuffre Randall Michael | Director | A-Award | A | Stock Option (right to buy) | 12,950 | 4.60 | 59.6K | 12,950 | — | ↗ |
| 2019-06-24 | ALCORN HARRY W JR | Officer | A-Award | A | Stock Option (right to buy) | 125,000 | 4.60 | 575.0K | 125,000 | — | ↗ |
| 2019-05-31 | Pilnik Richard D. | Director | P-Purchase | A | Voting Common Shares, no par value per share | 19,000 | 2.80 | 53.2K | 42,838 | — | ↗ |
| 2019-05-24 | Kellen Scott | Officer | P-Purchase | A | Voting Common Shares, no par value per share | 4,000 | 2.94 | 11.8K | 7,290 | — | ↗ |
| 2019-03-28 | ALCORN HARRY W JR | Officer | G-Gift | D | Voting Common Shares, no par value per share | 150 | 0.00 | — | 1,000 | — | ↗ |
| 2019-03-27 | ALCORN HARRY W JR | Officer | P-Purchase | A | Voting Common Shares, no par value per share | 150 | 4.46 | 668.39 | 1,150 | — | ↗ |
| 2018-12-11 | Xiao Zhenyu | Director / 10% Owner | P-Purchase | A | Voting Common Shares, no par value per share | 3,250 | 4.00 | 13.0K | 7,100 | — | ↗ |
| 2018-12-11 | Verdoorn Todd A. | Officer | P-Purchase | A | Voting Common Shares, no par value per share | 1,000 | 4.00 | 4.0K | 2,000 | — | ↗ |
| 2018-12-11 | Pilnik Richard D. | Director | P-Purchase | A | Voting Common Shares, no par value per share | 6,250 | 4.00 | 25.0K | 23,838 | — | ↗ |
| 2018-12-11 | Pauls Dietrich John | Director / Officer | P-Purchase | A | Voting Common Shares, no par value per share | 5,000 | 4.00 | 20.0K | 29,804 | — | ↗ |
| 2018-12-11 | Parsons James T. | Director | P-Purchase | A | Voting Common Shares, no par value per share | 2,250 | 4.00 | 9.0K | 6,100 | — | ↗ |
| 2018-12-11 | Kellen Scott | Officer | P-Purchase | A | Voting Common Shares, no par value per share | 1,250 | 4.00 | 5.0K | 3,290 | — | ↗ |
| 2018-12-11 | Giuffre Randall Michael | Director | P-Purchase | A | Voting Common Shares, no par value per share | 11,250 | 4.00 | 45.0K | 85,804 | — | ↗ |
| 2018-12-11 | ALCORN HARRY W JR | Officer | P-Purchase | A | Voting Common Shares, no par value per share | 1,000 | 4.00 | 4.0K | 1,000 | — | ↗ |
| 2018-12-06 | Xiao Zhenyu | Director / 10% Owner | — | I | Voting Common Shares, no par value per share | 0 | 0.00 | — | 1,000,000 | — | ↗ |
| 2018-12-06 | Verdoorn Todd A. | Officer | — | D | Voting Common Shares, no par value per share | 0 | 0.00 | — | 1,000 | — | ↗ |
| 2018-12-06 | Pilnik Richard D. | Director | — | D | Stock Option (right to buy) | 24,000 | 2.26 | 54.2K | 0 | — | ↗ |
| 2018-12-06 | Pauls Dietrich John | Director / Officer | — | D | Voting Common Shares, no par value per share | 0 | 0.00 | — | 24,804 | — | ↗ |
| 2018-12-06 | Parsons James T. | Director | — | D | Voting Common Shares, no par value per share | 0 | 0.00 | — | 3,850 | — | ↗ |
| 2018-12-06 | Kellen Scott | Officer | — | D | Voting Common Shares, no par value per share | 0 | 0.00 | — | 2,040 | — | ↗ |
| 2018-12-06 | Giuffre Randall Michael | Director | — | I | Voting Common Shares, no par value per share | 0 | 0.00 | — | 21,070 | — | ↗ |
| 2018-12-06 | ALCORN HARRY W JR | Officer | — | D | Stock Option (right to buy) | 25,000 | 7.83 | 195.8K | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
53.88M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Rick Pauls President and Chief Executive Officer | 645.0K | — | — | 1.65M | 412.5K | 17.5K | 2.73M | 60.59% | ↗ |
| 2 | 2025 | Julie Krop, M.D. Chief Medical Officer | 199.0K | — | — | 1.42M | 79.6K | 7.9K | 1.71M | 83.22% | ↗ |
| 3 | 2025 | Scott Kellen Chief Financial Officer and Secretary | 408.5K | — | — | 619.7K | 183.9K | 17.5K | 1.23M | 50.40% | ↗ |
| 4 | 2024 | Rick Pauls President and Chief Executive Officer | 593.3K | — | — | 633.5K | 307.0K | 17.3K | 1.55M | 40.85% | ↗ |
| 5 | 2024 | Lorianne Masuoka, M.D. Chief Medical Officer | 403.3K | — | — | 637.3K | 116.7K | 17.1K | 1.17M | 54.27% | ↗ |
| 6 | 2024 | Scott Kellen Chief Financial Officer and Secretary | 374.3K | — | — | 274.5K | 147.9K | 17.3K | 814.0K | 33.73% | ↗ |
| 7 | 2023 | Rick Pauls President and Chief Executive Officer | 562.0K | — | — | 396.6K | 240.0K | 16.7K | 1.22M | 32.63% | ↗ |
| 8 | 2023 | Scott Kellen Chief Financial Officer and Secretary | 352.8K | — | — | 146.8K | 116.0K | 16.7K | 632.2K | 23.22% | ↗ |
| 9 | 2023 | Kirsten Gruis, M.D. Former Chief Medical Officer | 298.6K | — | — | 146.8K | — | 150.7K | 596.1K | 24.63% | ↗ |
| 10 | 2023 | Julie Daves SVP, Clinical Development Operations | 306.8K | — | — | 118.3K | 91.7K | 16.7K | 533.4K | 22.18% | ↗ |
| 11 | 2022 | Rick Pauls President and Chief Executive Officer | 522.8K | — | — | 343.8K | 198.3K | 15.7K | 1.08M | 31.82% | ↗ |
| 12 | 2022 | Kirsten Gruis, M.D. Chief Medical Officer | 364.2K | — | — | 487.8K | 137.1K | 15.7K | 1.00M | 48.55% | ↗ |
| 13 | 2022 | Kirsten Gruis, M.D. Former Chief Medical Officer | 364.2K | — | — | 487.8K | 137.1K | 15.7K | 1.00M | 48.55% | ↗ |
| 14 | 2022 | Scott Kellen Chief Financial Officer and Secretary | 329.4K | — | — | 116.5K | 102.0K | 15.7K | 563.6K | 20.68% | ↗ |
| 15 | 2021 | Rick Pauls President and Chief Executive Officer | 477.4K | — | — | 452.1K | 191.6K | 15.1K | 1.14M | 39.79% | ↗ |
| 16 | 2021 | Scott Kellen Chief Financial Officer and Secretary | 286.2K | — | — | 155.0K | 90.5K | 15.1K | 546.7K | 28.35% | ↗ |
| 17 | 2021 | Harry Alcorn, Jr., Pharm.D. Senior Vice President of Clinical Operations | 302.1K | — | — | 155.0K | 73.1K | 15.1K | 545.3K | 28.43% | ↗ |
| 18 | 2020 | Rick Pauls President and Chief Executive Officer | 455.0K | — | — | 190.6K | 217.7K | 14.9K | 878.2K | 21.71% | ↗ |
| 19 | 2020 | Harry Alcorn, Jr., Pharm.D. Senior Vice President of Clinical Operations | 291.4K | — | — | 119.1K | 83.7K | 14.9K | 509.1K | 23.40% | ↗ |
| 20 | 2020 | Harry Alcorn, Jr., Pharm.D. Chief Medical Officer | 291.4K | — | — | 119.1K | 83.7K | 14.9K | 509.1K | 23.40% | ↗ |
| 21 | 2020 | Scott Kellen Chief Financial Officer and Secretary | 276.1K | — | — | 119.1K | 79.2K | 14.9K | 489.3K | 24.35% | ↗ |
| 22 | 2019 | Harry Alcorn, Jr., Pharm.D. Chief Medical Officer | 273.8K | — | — | 421.8K | 68.4K | 14.4K | 778.3K | 54.19% | ↗ |
| 23 | 2019 | Rick Pauls President and Chief Executive Officer | 420.0K | — | — | 890.7K | 178.0K | 14.7K | 733.7K | 121.40% | ↗ |
| 24 | 2019 | Scott Kellen Chief Financial Officer and Secretary | 262.5K | — | — | 336.6K | 64.8K | 14.0K | 677.8K | 49.65% | ↗ |
| 25 | 2018 | Rick Pauls President and Chief Executive Officer | 315.2K | — | — | 241.3K | 163.9K | 13.3K | 733.7K | 32.89% | ↗ |
| 26 | 2018 | Scott Kellen Chief Financial Officer and Secretary | 200.8K | — | — | 362.0K | 70.2K | 9.9K | 642.9K | 56.30% | ↗ |
| 27 | 2018 | Todd Verdoorn, Ph.D. Chief Scientific Officer | 221.7K | — | — | 156.8K | 36.0K | 8.9K | 423.4K | 37.05% | ↗ |
| 28 | 2017 | Rick Pauls President and Chief Executive Officer | 280.0K | 36.7K | — | 167.7K | — | 17.6K | 502.0K | 33.42% | ↗ |
| 29 | 2017 | Todd Verdoorn, Ph.D. Chief Scientific Officer | 200.0K | 40.0K | — | 98.7K | — | 7.2K | 345.9K | 28.53% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dietrich John Pauls | President, Chief Executive Officer & Director | 1M | male |
| Julie Krop | Chief Medical Officer | 675.7K | — |
| Scott Kellen | Chief Financial Officer & Corporate Secretary | 609.9K | male |
| Ambarish Shah | Chief Technology Officer | — | — |
| Dominic R. Cundari | Chief Commercial Officer | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DMAC
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
